
Biolojic Design
Biolojic Design is a biopharmaceutical company dedicated to the development of human antibody-based therapeutics for cancer and other diseases.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
$4.0m | Late VC | ||
Total Funding | 000k |
Related Content
Biolojic Design is a biotechnology company specializing in the development of Multibodies, which are multi-specific human antibodies that precisely target one or more predefined epitopes. Utilizing advanced AI, computational biology, and molecular tools, Biolojic customizes antibody properties to tackle difficult and complex targets such as ion channels and GPCRs. The company operates in the biopharmaceutical market, serving clients in the pharmaceutical and biotech industries who are focused on innovative therapeutic solutions. Biolojic's business model revolves around the creation and licensing of its proprietary Multibody technology, generating revenue through partnerships and collaborations with major pharmaceutical companies. The company aims to solve the most challenging problems in therapy design, driven by a passion to profoundly improve lives.
Keywords: Multibodies, AI-driven, computational biology, therapeutic solutions, biopharmaceutical, ion channels, GPCRs, antibody customization, drug development, biotechnology.